Literature DB >> 4038761

Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis.

P Westermark, P Pitkänen, L Benson, A Vahlquist, B O Olofsson, G G Cornwell.   

Abstract

In a series of 13 elderly patients with proven prealbumin-related senile systemic amyloidosis (SSA), depressed serum prealbumin values (110.7 +/- 14.1 micrograms/ml) were found as compared to an age-matched control group (175.1 +/- 20.3 micrograms/ml). As expected, there was a significant correlation between serum prealbumin and serum retinol-binding proteins in both groups of patients. Patients with reactive amyloid protein AA amyloidosis had slightly depressed serum prealbumin concentrations, whereas patients with prealbumin-related familial amyloidosis of Swedish type had prealbumin values within normal limits. Since the serum levels of the acute phase reactants, haptoglobin and amyloid-related serum protein AA, were higher in the group of patients with reactive amyloidosis than in patients with SSA, the depression of the prealbumin levels in SSA is not a result of inflammation. Since SSA is known to contain prealbumin, it is possible that a disturbed prealbumin metabolism in old age results in low prealbumin serum values and deposition of amyloid.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038761

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  "Sporadic" prealbumin-related amyloid polyneuropathy: report of two cases.

Authors:  M Yamada; H Tsukagoshi; J Satoh; S Ishiai; M Nakazato; H Furuya; H Sasaki; Y Sakaki; T Yokota
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

2.  Morphological diagnosis of vascular and senile dementia (the importance of cerebral congophilic angiopathy).

Authors:  R V Geinisman; E E Oksova
Journal:  Neurosci Behav Physiol       Date:  1989 Nov-Dec

3.  A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.

Authors:  Malin Olsson; Nina Norgren; Konen Obayashi; Violaine Plante-Bordeneuve; Ole B Suhr; Kristina Cederquist; Jenni Jonasson
Journal:  BMC Med Genet       Date:  2010-09-14       Impact factor: 2.103

4.  Specific pathogen free conditions prevent transthyretin amyloidosis in mouse models.

Authors:  Seiya Inoue; Mika Ohta; Zhenghua Li; Gang Zhao; Yutaka Takaoka; Naomi Sakashita; Kazuhisa Miyakawa; Koji Takada; Hajime Tei; Misao Suzuki; Michio Masuoka; Yoshiyuki Sakaki; Kiyoshi Takahashi; Ken-Ichi Yamamura
Journal:  Transgenic Res       Date:  2008-03-21       Impact factor: 2.788

5.  Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.

Authors:  P D Gorevic; F C Prelli; J Wright; M Pras; B Frangione
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity.

Authors:  Joel Buxbaum; James Koziol; Lawreen H Connors
Journal:  Amyloid       Date:  2008-12       Impact factor: 7.141

7.  Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.

Authors:  Yutaka Takaoka; Mika Ohta; Kazuhisa Miyakawa; Osamu Nakamura; Misao Suzuki; Kiyoshi Takahashi; Ken-Ichi Yamamura; Yoshiyuki Sakaki
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.